Your Article Summary
See Latest ArticlesPharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: An open-label, randomized-sequence, three-treatment, three-way crossover study
Clinical Therapeutics, 06/23/09
Cho SH et al. - The new formulation of rhEPO met the regulatory criteria for bioequivalence in these healthy Korean adult male volunteers. All formulations were generally well tolerated.
Related Articles
Extracts from The Cochrane Library: Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer
Otolaryngology Head and Neck Surgery, 10/12/09
Relevance Score: 87%
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Haematologica, 10/21/09
Relevance Score: 85%
Removal of erythropoietin from anaemia trauma practice guideline does not increase red blood cell transfusions and decreases hospital utilization costs
Injury, 11/25/09
Relevance Score: 84%
School of Pharmacy Hopes to Close Clinical Gap for Elderly Blood Disorder
Internet Source, 11/05/09
Relevance Score: 84%
Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants
Journal of Pharmacology and Experimental Therapeutics, 10/09/09
Relevance Score: 84%
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
British Journal of Clinical Pharmacology, 11/30/09
Phase 1 Trial of Adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) Study Group
American Journal of Kidney Diseases, 11/30/09
Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide
British Journal of Clinical Pharmacology, 11/30/09